Home
Our ServicesConnect Education Workshops
HomeOur ServicesConnect Education Workshops
Living with Acute Myelogenous Leukemia (AML)
Listen Now
Topics Covered
- Overview of Acute Myelogenous Leukemia (AML), in the Context of COVID-19
- Current Treatment Options
- Transplantation as a Treatment Option for AML
- New Therapies
- Clinical Trial Updates
- How Clinical Trials Increase Your Treatment Options
- Symptom and Pain Management Tips
- Important Questions to Ask When Communicating with Your Health Care Team
- How to Prepare for Telehealth Appointments
- Quality-of-Life Concerns
- Questions for Our Panel of Experts
Our Panel of Experts
Farhad Ravandi, MD
Janiece and Stephen A. Lasher Professor of Medicine, Chief, Section of Departmental Therapeutics, Department of Leukemia, The University of Texas MD Anderson Cancer Center
Alexander Perl, MD
Associate Professor of Medicine, Leukemia Program, Division of Hematology/Oncology, University of Pennsylvania
Eytan M. Stein, MD
Hematologic Oncologist, Clinical Trialist, Acute Myeloid Leukemia, Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Director of Education and Training, CancerCare®
Brochure
You can download the brochure for this workshop 
Workshop Date
This workshop was originally recorded on June 19, 2020.